Retrospective analysis of adjuvant treatment for localized, operable uterine leiomyosarcoma.

Jomjit ChantharasameeKarlton WongPasathorn PotivongsajarnAmir QorbaniNeda MotamedSandra BrackertJoshua CohenBartosz ChmielowskiAnusha KalbasiJianyu RaoScott NelsonArun Singh

Published in: Cancer medicine (2022)

Though DFS was more favorable among those who received adjuvant therapy, it was not statistically significant, and thus based on this data adjuvant therapy for resected uLMS is still in question.

Keyphrases

early stage
lymph node
electronic health record
big data
combination therapy
artificial intelligence
deep learning
data analysis